bioRxivBioengineeringPreprint
Competitive, connective and allosteric Nanobodies that modulate the SOS1-RAS protein-protein interactions and tune the nucleotide exchange rate as a starting point for drug design
B. Fischer, T. Uchanski, A. Sheryazdanova, S. Gonzalez, A. N. Volkov, E. Brosens, T. Zogg, V. V. Kalichuk, S. Ballet, W. Versees, A. A. Sablina, E. Pardon, A. Wohlkonig, J. Steyaert
Abstract
Protein-protein interactions (PPIs) are central in cell metabolism but research tools for the structural and functional characterization of these PPIs are often missing. Here we introduce novel and broadly applicable immunization (Cross-link PPIs and immunize llamas, ChILL) and selection strategies (Display and co-selection, DisCO) for the discovery of diverse Nanobodies that either stabilize or disrupt PPIs in a single experiment. We applied ChILL and DisCO to identify competitive, connective or fully allosteric Nanobodies that inhibit or facilitate the formation of the SOS1*RAS complex and modulate the nucleotide exchange rate on this pivotal GTPase in vitro and RAS signalling in cellulo. One of these connective Nanobodies fills a cavity that was previously identified as the binding pocket for a series of therapeutic lead compounds. The long complementarity-determining region (CDR3) that penetrates this binding pocket serves as an innovative pharmacophore for extending the repertoire of potential leads.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nanobody CDR3 mimetics enhance SOS1-catalyzed nucleotide exchange on RAS
K. Van holsbeeck, B. Fischer, … S. Ballet·bioRxiv·Dec 9, 2022
- HDX-MS optimized approach to characterize nanobodies as tools for biochemical and structural studies of class IB phosphoinositide 3-kinases
M. K. Rathinaswamy, K. D. Fleming, … J. E. Burke·bioRxiv·Jun 1, 2021
- Protease-Containing Nanobodies for Detecting and Manipulating Intracellular Antigens Using Antiviral Drugs
Quan Le, John T. Ngo·ACS Chemical BiologyPeer-reviewed·May 12, 2025
- K-Ras G-domain binding with signaling lipid phosphoinositides: PIP2 association, orientation, function
Shufen Cao, Stacey Chung, … Matthias Buck·bioRxiv·May 16, 2018
- Discovery of a new drug using lipid-based formulation targeting G12D mutated KRAS4B through non-covalent bonds
Huixia Lu, Zheyao Hu, … Jordi Martı́·bioRxiv·Apr 5, 2023
- RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site.
Katarzyna Z. Haza, Heather L. Martin, … Darren Charles Tomlinson·Nature CommunicationsPeer-reviewed·Jun 30, 2021